CompuGroup Stock - analyst consensus and earnings outlook

CompuGroup Medical draws investor attention at the start of the week as markets look at analyst consensus, valuation and the upcoming earnings calendar. The healthcare IT provider remains a mid-cap reference name in European digital health.

Edited by ad hoc news Earnings & Calendar Desk. Verified prior to publication on 06/22/2026, 08:27 CET. Details in the imprint.

CompuGroup (DE000A288904) is starting the new week without fresh price-sensitive headlines but with investors watching estimates and the earnings calendar. The stock remains a core European e-health name with stable recurring revenue, according to analyst data.

What analyst estimates show

There is no new rating action on CompuGroup Medical from major houses such as Deutsche Bank or Berenberg over the past 24 hours, according to a review of recent research headlines. The existing coverage focuses on digital health growth and margin improvement.

Consensus data compiled by market services points to modest revenue growth and slightly improving profitability for the current fiscal year, reflecting recurring software income in clinics and practices. The distribution of ratings remains mixed between Buy and Hold, with few explicit Sell recommendations.

Weekly outlook and earnings calendar

CompuGroup’s official investor relations calendar lists upcoming financial reports and events but shows no scheduled earnings release for this week. The next major catalyst is expected with the publication of the next quarterly figures, on a date already flagged on the company website.

Investors are also watching sector news in European healthcare IT, where digitalization initiatives and e-prescription projects can influence spending patterns in hospitals and physician practices. That macro backdrop tends to feed into expectations for CompuGroup’s order intake and backlog over the coming quarters.

How the company makes money

CompuGroup Medical develops and sells healthcare software for doctors, dentists, pharmacies and hospitals, including practice management systems, electronic patient records and e-prescription solutions. The business model is built on license fees, maintenance contracts and growing cloud-based subscriptions.

Where the stock trades today

The shares of CompuGroup Medical SE & Co. KGaA (DE000A288904) trade on Xetra; the latest verified euro price data are available on the German exchange portals and the company’s investor relations page.

Key facts on CompuGroup stock

• Company: CompuGroup Medical SE & Co. KGaA
• ISIN: DE000A288904
• WKN: A28890
• Ticker: COP
• Venue: Xetra
• Sector / Industry: Health Care - Health Care Technology
• Index membership: TecDAX, SDAX
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.